1003 related articles for article (PubMed ID: 16366133)
1. Amiodarone-induced thyroid dysfunction in cardiac patients from areas with iodine deficiency.
Trifănescu R; Fica S; Barbu C; Vârtej I; Ursu H; Bunghez R; Coculescu M
Rom J Intern Med; 2004; 42(3):595-605. PubMed ID: 16366133
[TBL] [Abstract][Full Text] [Related]
2. Management of amiodarone-induced thyrotoxicosis in Latin America: an electronic survey.
Diehl LA; Romaldini JH; Graf H; Bartalena L; Martino E; Albino CC; Wiersinga WM
Clin Endocrinol (Oxf); 2006 Oct; 65(4):433-8. PubMed ID: 16984234
[TBL] [Abstract][Full Text] [Related]
3. Radioiodine therapy in patients with amiodarone-induced thyrotoxicosis (AIT).
Czarnywojtek A; Czepczynski R; Ruchala M; Wasko R; Zgorzalewicz-Stachowiak M; Szczepanek E; Zamyslowska H; Bartkowiak Z; Florek E; Sowinski J
Neuro Endocrinol Lett; 2009; 30(2):209-14. PubMed ID: 19675515
[TBL] [Abstract][Full Text] [Related]
4. [Amiodarone and thyroid disorders--prospective study and review of the literature].
Vandergheynst F; Liénart F; Ducobu J
Rev Med Brux; 1999 Oct; 20(5):411-7. PubMed ID: 10582476
[TBL] [Abstract][Full Text] [Related]
5. Amiodarone-induced thyrotoxicosis. A review.
Piga M; Serra A; Boi F; Tanda ML; Martino E; Mariotti S
Minerva Endocrinol; 2008 Sep; 33(3):213-28. PubMed ID: 18846027
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic particularities in amiodarone induced thyroid disorder in patients with underlying cardiac condition.
Costache L; Mogos V; Preda C; Vulpoi C; Ungureanu MC
Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):959-64. PubMed ID: 25581954
[TBL] [Abstract][Full Text] [Related]
7. [Iodine-induced hyperthyroidism (iodine-induced Basedow's disease): a current disease picture].
Henzen C; Buess M; Brander L
Schweiz Med Wochenschr; 1999 May; 129(17):658-64. PubMed ID: 10407936
[TBL] [Abstract][Full Text] [Related]
8. Thyroid color flow doppler sonography and radioiodine uptake in 55 consecutive patients with amiodarone-induced thyrotoxicosis.
Bogazzi F; Martino E; Dell'Unto E; Brogioni S; Cosci C; Aghini-Lombardi F; Ceccarelli C; Pinchera A; Bartalena L; Braverman LE
J Endocrinol Invest; 2003 Jul; 26(7):635-40. PubMed ID: 14594114
[TBL] [Abstract][Full Text] [Related]
9. Effect of amiodarone on thyroid hormone economy.
Posner J; Sobel RJ; Glick S
Isr J Med Sci; 1984 Feb; 20(2):113-7. PubMed ID: 6423565
[TBL] [Abstract][Full Text] [Related]
10. Radioiodine ablation of the thyroid to allow the reintroduction of amiodarone treatment in patients with a prior history of amiodarone-induced thyrotoxicosis.
Hermida JS; Jarry G; Tcheng E; Moullart V; Arlot S; Rey JL; Delonca J; Schvartz C
Am J Med; 2004 Mar; 116(5):345-8. PubMed ID: 14984821
[No Abstract] [Full Text] [Related]
11. [The effects of amiodaron on the thyroid function].
Kucharczyk P; Michałkiewicz D; Kucharczyk A
Pol Merkur Lekarski; 2006 Jul; 21(121):86-9. PubMed ID: 17007301
[TBL] [Abstract][Full Text] [Related]
12. [Amiodarone and thyroid function: clinical implications].
Binz K; Burger A; Vallotton MB
Schweiz Med Wochenschr; 1998 Jun; 128(26):1051-8. PubMed ID: 9700779
[TBL] [Abstract][Full Text] [Related]
13. Serum sex hormone-binding globulin in amiodarone-treated patients. A marker for tissue thyrotoxicosis.
Bambini G; Aghini-Lombardi F; Rosner W; Khan MS; Martino E; Pinchera A; Braverman LE; Safran M
Arch Intern Med; 1987 Oct; 147(10):1781-5. PubMed ID: 3662707
[TBL] [Abstract][Full Text] [Related]
14. [Cardiovascular manifestations of thyrotoxicosis and thyroid dysfunction caused by amiodarone].
Simkó J; Barta K; Szabó Z; Varga E; Nagy E; Lorincz I
Orv Hetil; 2004 Nov; 145(48):2411-7. PubMed ID: 15638034
[TBL] [Abstract][Full Text] [Related]
15. [Prevention of recurrent amiodarone-induced hyperthyroidism by iodine-131].
Hermida JS; Jarry G; Tcheng E; Moullart V; Arlot S; Rey JL; Schvartz C
Arch Mal Coeur Vaiss; 2004 Mar; 97(3):207-13. PubMed ID: 15106744
[TBL] [Abstract][Full Text] [Related]
16. Radioiodine ablation of the thyroid to prevent recurrence of amiodarone-induced thyrotoxicosis in patients with resistant tachyarrhythmias.
Hermida JS; Tcheng E; Jarry G; Moullart V; Arlot S; Rey JL; Delonca J; Schvartz C
Europace; 2004 Mar; 6(2):169-74. PubMed ID: 15018878
[TBL] [Abstract][Full Text] [Related]
17. Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis.
Loy M; Perra E; Melis A; Cianchetti ME; Piga M; Serra A; Pinna G; Mariotti S
Acta Radiol; 2007 Jul; 48(6):628-34. PubMed ID: 17611870
[TBL] [Abstract][Full Text] [Related]
18. Determinants and outcome of amiodarone-associated thyroid dysfunction.
Ahmed S; Van Gelder IC; Wiesfeld AC; Van Veldhuisen DJ; Links TP
Clin Endocrinol (Oxf); 2011 Sep; 75(3):388-94. PubMed ID: 21535072
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European thyroidologists.
Tanda ML; Piantanida E; Lai A; Liparulo L; Sassi L; Bogazzi F; Wiersinga WM; Braverman LE; Martino E; Bartalena L
Clin Endocrinol (Oxf); 2008 Nov; 69(5):812-8. PubMed ID: 18410546
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of amiodarone-induced thyrotoxicosis and hypothyroidism in Japan.
Sato K; Miyakawa M; Eto M; Inaba T; Matsuda N; Shiga T; Ohnishi S; Kasanuki H
Endocr J; 1999 Jun; 46(3):443-51. PubMed ID: 10503998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
